Clinical trials
Phase 1/2 Breast Neoplasms trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 7 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 11 |
| Active, not recruiting | 5 |
| Completed | 5 |
| Terminated | 3 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 3 |
| Eli Lilly and Company | 3 |
| Pfizer | 3 |
| Novartis Pharmaceuticals | 2 |
| Tokyo University | 2 |
| Astellas Pharma Global Development, Inc. | 1 |
| Boehringer Ingelheim | 1 |
| Daiichi Sankyo | 1 |
| Daiichi Sankyo Co., Ltd. | 1 |
| Genmab | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 25 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Ovarian Neoplasms | 6 |
| Endometrial Neoplasms | 5 |
| Neoplasms | 5 |
| Uterine Cervical Neoplasms | 4 |
| Head and Neck Neoplasms | 3 |
| Neoplasms by Site | 3 |
| Prostatic Neoplasms | 3 |
| Stomach Neoplasms | 3 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.